Eli Lilly stock soars on obesity drug success. See here to know why LLY remains a top pick with strong growth prospects and a ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Nausea, a major hurdle for millions using weight-loss drugs like Ozempic, may soon be a thing of the past. Researchers are ...

(THE CONVERSATION) The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the ...

Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...

Eli Lilly has officially entered the elite $1 trillion market-value club, becoming the first pharmaceutical company to reach ...

Eli Lilly has made history by becoming the first healthcare company to reach a $1 trillion market cap, thanks to the success ...

Stomach cancer is a malignant tumor that begins in the stomach lining, often caused by abnormal cell growth due to DNA ...